Auxilium Pharmaceuticals promotes James Tursi

Becomes chief medical officer having worked for US firm since 2009

Auxilium Pharmaceuticals, a US specialist biopharmaceutical company, has promoted James Tursi to chief medical officer. He has worked for Auxilium since March 2009 and has been responsible for the oversight of clinical development, clinical operations, biometrics and medical writing.

Tursi entered the pharmaceutical industry in 2004 as a medical director for Procter and Gamble Pharmaceuticals. He worked on several products and therapeutic areas, including female sexual dysfunction, overactive bladder, and osteoporosis. His responsibilities included clinical development and medical affairs. He moved to GlaxoSmithKline Biologicals in 2006 and directed all Medical Affairs responsibilities for cancer vaccines in North America.

You may also like

Pharmaceutical

Ardena strengthens executive team to drive its next phase of growth

Ghent, Belgium, 4 May 2026 – Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further strengthen Ardena’s executive leadership team as the company continues to scale its operations and commercial reach globally
Pharmaceutical

Backed by investments exceeding $1 billion, PCI Pharma Services announces major expansion of US sterile fill-finish and drug-device delivery combination capabilities

As pharma manufacturers prioritise US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging
Manufacturing

New Romaco Maximus 400 tablet coater at interpack

Ideal for pharmaceutical coatings with a very large weight gain
Pharmaceutical

SGS launches GMP-compliant NMR testing for Chinese pharma industry

The inspection and certification specialist will now offer nuclear magnetic resonance (NMR) testing for analysis of both drug substances and drug products across China
Media

Romaco to debut Maximus 400 tablet coater with automatic baffle adjustment at Interpack

The Maximus 400 tablet coater is the first to automatically adjust baffle geometry as tablet bed volume increases, with an optional energy recovery system cutting consumption by up to 50%, alongside the VENTILUS Lab fluid bed processor, capable of reducing batch processing times by 25%
Manufacturing

SCIEX expands integrated software ecosystem with six mass spectrometry workflow collaborations

The firm has announced six software collaborations designed to unify instrument control, data processing and compliance within a single analytical environment, with more partnerships set to be revealed at ASMS 2026
Pharmaceutical

Batch recovery or batch rejection? Making better decisions when weight variability appears

Recent regulatory and quality-system developments are a reminder that decisions in pharmaceutical operations must be evidence-based, proportionate, and capable of standing up to scrutiny
Subscribe now